Technology
Health
Medical

Heska

$87.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$2.48 (2.91%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Heska and other stocks, options, ETFs, and crypto commission-free!

About

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through two segments: Core Companion Animal Health and Other Vaccines & Pharmaceuticals. Read More The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The Other Vaccines & Pharmaceuticals segment focuses on private label vaccine and pharmaceutical production, primarily for cattle, but also for equine, porcine, avian, feline, and canine. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Employees
347
Headquarters
Loveland, Colorado
Founded
1988
Market Cap
654.89M
Price-Earnings Ratio
120.78
Dividend Yield
0.00
Average Volume
55.47K
High Today
$87.98
Low Today
$84.49
Open Price
$85.97
Volume
33.23K
52 Week High
$114.50
52 Week Low
$71.60

Collections

Technology
Health
Medical
Software Service
Pharmaceutical
US
North America

News

Simply Wall St14h

Read This Before Buying Heska Corporation (NASDAQ:HSKA) Shares

We’ve lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So we’ll take a look at whether insiders have been buying or selling shares in Heska Corporation (NASDAQ:HSKA). Do Insider Transactions Matter? It’s quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, s...

2
BenzingaMar 8

Heska Corporation Announces New Board Member Mark Furlong

LOVELAND, Colo., March 8, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA, ", Heska", or the ", Company", )), a provider of advanced veterinary diagnostic and specialty products, announced that Mark Furlong has joined the Company's Board of Directors (the "Board"). Mr. Furlong is the former President and Chief Executive Officer of BMO Harris Bank, N.A., a role he held from the acquisition of Marshall & Ilsley Corporation by BMO Financial Group in 2011 until his retirement in June 2015. He joined Marsha...

9
Guru FocusMar 7

Heska Corp (HSKA) Files 10-K for the Fiscal Year Ended on December 31, 2018

Heska Corp (NASDAQ:HSKA) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Heska Corp is engaged in developing, manufacturing, marketing, selling and supporting veterinary products.

4

Earnings

$0.16
$0.36
$0.56
$0.76
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 3, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.